Lower starting dose of roxadustat in non-dialysis-dependent chronic kidney disease patients with anaemia: a study protocol for a randomised, multicentre, open-label study
Introduction Roxadustat is a first-in-class oral therapy that treats chronic kidney disease (CKD) anaemia with the benefit of a novel mechanism of action that consistently corrects and maintains haemoglobin (Hb) across the spectrum of non-dialysis-dependent (NDD) CKD anaemia with an acceptable safet...
Shranjeno v:
| Principais autores: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Publishing Group
2023-02-01
|
| Serija: | BMJ Open |
| Online dostop: | https://bmjopen.bmj.com/content/13/2/e068864.full |
| Oznake: |
Brez oznak, prvi označite!
|